FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

415507003: Administration of second dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2005. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2530527013 Second diphtheria tetanus and five component acellular pertussis, haemophilus influenzae type b, inactivated polio vaccination (procedure) en Fully specified name Inactive Entire term case insensitive SNOMED CT core module
2533977019 Second diphtheria tetanus and five component acellular pertussis, haemophilus influenzae type b, inactivated polio vaccination en Synonym Inactive Entire term case insensitive SNOMED CT core module
3977426013 Administration of second dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type B and inactivated whole Human poliovirus antigens (procedure) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
3977427016 Administration of second dose of diphtheria and Haemophilus influenza B and five component acellular pertussis and inactivated poliomyelitis and tetanus vaccine en Synonym Inactive Only initial character case insensitive SNOMED CT core module
3977428014 Administration of second dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type B and inactivated whole Human poliovirus antigens en Synonym Inactive Only initial character case insensitive SNOMED CT core module
3977429018 Second diphtheria and Haemophilus influenza B and five component acellular pertussis and inactivated poliomyelitis and tetanus immunization en Synonym Inactive Only initial character case insensitive SNOMED CT core module
3977430011 Second diphtheria and Haemophilus influenza B and five component acellular pertussis and inactivated poliomyelitis and tetanus immunisation en Synonym Inactive Only initial character case insensitive SNOMED CT core module
3977431010 Second diphtheria and Haemophilus influenza B and five component acellular pertussis and inactivated poliomyelitis and tetanus vaccination en Synonym Inactive Only initial character case insensitive SNOMED CT core module
5088687011 Second diphtheria and Haemophilus influenza type b and five component acellular pertussis and inactivated poliomyelitis and tetanus immunisation en Synonym Active Only initial character case insensitive SNOMED CT core module
5088688018 Administration of second dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure) en Fully specified name Active Only initial character case insensitive SNOMED CT core module
5088689014 Second diphtheria and Haemophilus influenza type b and five component acellular pertussis and inactivated poliomyelitis and tetanus vaccination en Synonym Active Only initial character case insensitive SNOMED CT core module
5088690017 Second diphtheria and Haemophilus influenza type b and five component acellular pertussis and inactivated poliomyelitis and tetanus immunization en Synonym Active Only initial character case insensitive SNOMED CT core module
5088691018 Administration of second dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens en Synonym Active Only initial character case insensitive SNOMED CT core module
5088692013 Administration of second dose of diphtheria and Haemophilus influenza type b and five component acellular pertussis and inactivated poliomyelitis and tetanus vaccine en Synonym Active Only initial character case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Administration of second dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens Is a Administration of vaccine product containing bacteria and virus antigens false Inferred relationship Existential restriction modifier
Administration of second dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens Direct substance Vaccine and biological substance false Inferred relationship Existential restriction modifier 1
Administration of second dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens Method Administration - action false Inferred relationship Existential restriction modifier 1
Administration of second dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens Direct substance Vaccine false Inferred relationship Existential restriction modifier 1
Administration of second dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens Method Introduction of substance false Inferred relationship Existential restriction modifier 1
Administration of second dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens Method Administration - action false Inferred relationship Existential restriction modifier 1
Administration of second dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens Direct substance Vaccine false Inferred relationship Existential restriction modifier 1
Administration of second dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens Method Administration - action true Inferred relationship Existential restriction modifier 1
Administration of second dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens Direct substance Vaccine false Inferred relationship Existential restriction modifier 1
Administration of second dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens Is a Administration of vaccine product containing only five component acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and inactivated whole Human poliovirus antigens true Inferred relationship Existential restriction modifier
Administration of second dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens Direct substance Vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (medicinal product) true Inferred relationship Existential restriction modifier 1

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start